Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease
- PMID: 32579980
- PMCID: PMC7306204
- DOI: 10.1016/j.jinf.2020.06.049
Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease
Keywords: Clinical deterioration; Covid-19; Mortality; Remdesivir; Risk score.
Conflict of interest statement
Declaration of Competing Interest None to declare.
Figures
Comment on
-
Clinical Characteristics and Predictors of Outcomes of Hospitalized Patients With Coronavirus Disease 2019 in a Multiethnic London National Health Service Trust: A Retrospective Cohort Study.Clin Infect Dis. 2021 Dec 6;73(11):e4047-e4057. doi: 10.1093/cid/ciaa1091. Clin Infect Dis. 2021. PMID: 32766823 Free PMC article.
References
-
- UK Department of Health & Social Care. Early Access to Medicines Scheme for remdesivir in the treatment of COVID-19. 2020; published online May 26. https://www.gov.uk/government/publications/early-access-to-medicines-sch... (Accessed 25 May 2020).
-
- Hall F., Jayne D.Multi-Arm Therapeutic Study in Pre-ICU Patients Admitted with COVID-19. 2020. https://cctu.org.uk/portfolio/COVID-19/TACTIC/TACTIC-R (Accessed 26 May 2020). - PMC - PubMed
-
- Sneep R., Cantle F., Brookes A. et al. Early Epidemiological and Clinical Analysis of the First 200 Patients with COVID-19 Admitted via the Emergency Department in King's College Hospital, London: a Retrospective Cohort Stodu (4/9/20). Available at SSRN:https://ssrn.com/abstract=3576791 / 10.2139/ssrn.3576791 (Accessed 9 April 2020) - DOI
-
- Perez Guzman P., Daunt A., Mukherjee S., et al. Report 17: clinical characteristics and predictors of outcomes of hospitalised patients with COVID-19 in a London NHS Trust: a retrospective cohort study. Imperial College London, 2020 DOI:10.25561/78613.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
